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ABSTRACT
Background Prescribing errors occur in up to
15% of UK inpatient medication orders.
However, junior doctors report insufficient
feedback on errors. A barrier preventing
feedback is that individual prescribers often
cannot be clearly identified on prescribing
documentation.
Aim To reduce prescribing errors in a UK
hospital by improving feedback on prescribing
errors.
Interventions We developed three linked
interventions using plan–do–study–act cycles:
(1) name stamps for junior doctors who were
encouraged to stamp or write their name clearly
when prescribing; (2) principles of effective
feedback to support pharmacists to provide
feedback to doctors on individual prescribing
errors and (3) fortnightly prescribing advice emails
that addressed a common and/or serious error.
Implementation and evaluation Interventions
were introduced at one hospital site in August
2013 with a second acting as control. Process
measures included the percentage of inpatient
medication orders for which junior doctors stated
their name. Outcome measures were junior
doctors’ and pharmacists’ perceptions of current
feedback provision (evaluated using quantitative
pre-questionnaires and post-questionnaires and
qualitative focus groups) and the prevalence of
erroneous medication orders written by junior
doctors between August and December 2013.
Results The percentage of medication orders for
which junior doctors stated their name increased
from about 10% to 50%. Questionnaire responses
revealed a significant improvement in pharmacists’
perceptions but no significant change for doctors.
Focus group findings suggested increased doctor
engagement with safe prescribing. Interrupted
time series analysis showed no difference in weekly
prescribing error rates between baseline and
intervention periods, compared with the control
site.
Conclusion Findings suggest improved
experiences around feedback. However, attempts
to produce a measurable reduction in prescribing
errors are likely to need a multifaceted approach of
which feedback should form part.
INTRODUCTION
Prescribing errors occur in 1%–15% of
medication orders written for UK hos-
pital inpatients, resulting in harm to an
estimated 1%–2%.1 Local studies suggest
a similar prevalence of error.2 While
there have been relatively few studies of
interventions to reduce them,3 a common
theme in UK studies of the causes of pre-
scribing errors2 4 5 is that hospital
doctors are often unaware of their errors.
Provision of explicit feedback to junior
doctors and encouragement of help-
seeking behaviours have been recom-
mended to address this.2 4–6 In the
improvement and implementation science
literature, feedback has been widely
studied as a means of improving out-
comes and changing professional behav-
iour.7 Research suggests that a number of
characteristics are important for effective
feedback, including perceived usefulness,
credibility, intensity, timeliness, relevance
and the presence of linked quality
improvement mechanisms.8–12
Previous work within our organisation
confirmed that lack of feedback was a
problem locally.2 We therefore wanted to
conduct a quality improvement study
aimed at reducing prescribing errors
through provision of feedback. We under-
took pilot work providing feedback to
teams of doctors13 and ascertained the
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acceptability of pharmacists providing more formal
feedback to junior doctors on an individual basis.14
However, a barrier was that individual prescribers
could only be identified for about 10% of individual
inpatient medication orders.15 Our basic logic
model16 (figure 1) was that improved prescriber iden-
tification and better provision of feedback17 on pre-
scribing errors would facilitate learning, reflection and
changes to practice. This would in turn reduce pre-
scribing errors. Drawing on prior research in the area
of audit and feedback, our theory of change was that
the implementation of timely, relevant feedback to
prescribers would effect changes in professional
behaviour and reduce prescribing errors.8–12 This
paper describes the development, testing and evalu-
ation of our approach, structured according to the
SQUIRE guidelines.18 Our objectives were to improve
prescriber identification on medication orders in
order to facilitate individual feedback and to provide
effective feedback to prescribers at both the individual
level and group level with the aim of reducing pre-
scribing errors.
METHODS
Setting
The study took place at two large teaching hospitals
within the same UK hospital organisation. We focused
on junior doctors, specifically foundation year 1
doctors (those in their first year post-medical school).
This group of doctors do a large proportion of pre-
scribing,5 having a relatively high prescribing error
rate,5 and good prescribing habits learnt early will
hopefully be continued throughout their career.
Online supplementary appendix S1 explains UK
medical staff grades. The interventions were devel-
oped and piloted with existing junior doctors and
pharmacists at the intervention hospital (site 1)
between February and July 2013. The interventions
were then implemented at this site concurrently with
the new cohort of junior doctors starting in August
2013. A second hospital (site 2) acted as control for
selected aspects of the evaluation. At any one time
there were 30–34 junior doctors at site 1, mainly
based on 12 wards, and 43–45 at site 2, again across
12 wards. Both sites used the same preformatted
paper medication charts on which medication orders
were handwritten for inpatients and electronic pre-
scriptions at discharge. Junior doctors generally
rotated between specialties within the same hospital
every 4 months.
Pharmacists provided a typical UK ward pharmacy
service, with wards generally visited by a pharmacist
for 1–3 h each weekday. Pharmacists checked inpatient
medication orders and discharge prescriptions to
ensure that they were clear, legal and clinically appro-
priate. Standard practice was that any prescribing
errors identified were rectified following discussion
with a prescriber, if necessary. If the original pre-
scriber could not easily be identified and/or contacted,
any available prescriber was asked to rectify the error.
Developing the interventions
Previous research suggests specific mechanisms that
maximise the effectiveness of feedback and its cap-
acity to elicit behavioural change. Feedback is most
effective when provided more than once, using both
verbal and written formats and including both explicit
targets and an action plan.7 19 To develop interven-
tions that incorporated this best practice, a panel of
six existing junior doctors was recruited to contribute
to initial development and testing using plan–do–
study–act (PDSA) cycles between February and July
2013. We focused on three linked interventions:
improving prescriber identification, developing an
agreed approach for pharmacists to use when provid-
ing feedback on individual prescribing errors and a
Figure 1 Logic model: basic high-level model depicting the planned inputs and intended results.16
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method of sharing learning among all junior doctors
following common or serious errors.
Intervention 1: prescriber identification
To facilitate prescriber identification on inpatient
medication charts, we used a multifaceted approach.
Junior doctors were given personalised name stamps
and were reminded to write or stamp their name
whenever prescribing on paper medication charts.
They were emailed fortnightly run charts showing
their compliance with prescriber identification as a
group, established by a member of the project team
using a signature log created for the project.
Following suggestions from junior doctors in early
PDSA cycles, we subsequently modified the emails to
include comparison among the three main clinical
specialities, which introduced an element of competi-
tion. The inpatient medication chart used on both
hospital sites was also modified to clearly specify that
the prescriber’s surname was required alongside their
signature and pager number.
Intervention 2: individual feedback
We worked with our panel of six junior doctors to
agree some principles of effective feedback plus a set
of phrases that they felt would clearly communicate
that an error had been made in a non-threatening
manner (box 1). Training sessions were held with
pharmacists to explain why and how to provide feed-
back on prescribing errors, incorporating quotes from
junior doctors to highlight the importance of appro-
priate feedback. Where possible, a junior doctor rep-
resentative attended to explain first hand why
feedback was valued. The principles were also incor-
porated into local clinical pharmacy standard operat-
ing procedures.
Intervention 3: shared learning
To support shared learning, ‘good prescribing tip’
emails were developed and sent fortnightly to site 1
junior doctors and pharmacists. Topics were based on
local incident reports or suggestions from pharmacy
or medical staff. Each prescribing tip (see online sup-
plementary appendix S2) focused on one specific
serious/common error and provided evidence-based
solutions, aligned with local guidelines. PDSA cycles
were used to develop materials perceived as relevant
by the target audience and visually appealing on both
desktops and smartphones.
Evaluation of the interventions
We used a mixed-methods approach with quantitative
and qualitative elements to evaluate changes in key
process and outcome measures as well as exploring
the experiences of the prescribers and pharmacists
involved.
Process measures
Prescriber identification
A signature log was created for all junior doctors; this
was used by a member of the project team to conduct
a weekly audit on the 12 wards on each site where
junior doctors were based. The first 10 available medi-
cation charts on each ward were examined for pre-
scriber identification (presence of a signature, plus
either a handwritten or stamped name) for junior
doctors’ medication orders. Prescriber identification
rates were compared pre-intervention and post-
intervention using a χ2 test.
Pharmacists’ provision of individual feedback
We added three extra criteria to the standard set of 43
criteria used to assess pharmacists during routine peer-
reviewed ward visits. Peer-reviewed visits were rou-
tinely conducted by senior clinical pharmacists
employed at the study hospitals based on a validated
approach20; the three extra criteria relating to feed-
back were added only at site 1. For any prescribing
errors identified, these new criteria established
whether pharmacists attempted to contact the initial
prescriber, whether they gave appropriate feedback
and whether they highlighted any relevant prescribing
resources. Each criterion was assessed on a 4-point
Likert scale (always, mostly, sometimes, never).20
Outcome measures
Junior doctors’ and pharmacists’ perceptions of feedback
Evaluative questionnaires (see online supplementary
appendix S3) were developed for both junior doctors
and pharmacists, including items based on character-
istics of effective feedback: perceived usefulness, cred-
ibility, intensity, timeliness, relevance and accuracy of
feedback.8–10 All measures were reported on an
8-point scale with higher values representing more
positive responses. Items were additionally combined
Box 1 Principles of effective feedback on indivi-
duals’ prescribing errors and suggested phrases to
use, developed from the literature8–10 and our panel
of six junior doctors
Principles of effective feedback
Feedback should:
▸ be as soon as possible after the event;
▸ ensure the prescriber is aware that an error has been
made;
▸ discuss possible solutions;
▸ highlight any relevant prescribing resources
(eg, clinical guidelines) and
▸ be non-judgemental and blame-free.
Suggested phrases
▸ ‘I want to highlight to you that there’s an error on
this drug chart. The correct way to prescribe it is…’.
▸ ‘This dose is incorrect for this patient: it should
be……here’s where you find the protocol’.
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into a mean overall feedback effectiveness scale score
(Cronbach’s α 0.904 for pharmacists and 0.853 for
junior doctors). The questionnaire was administered
at site 1 during spring 2013 (pre-intervention) and
again in spring 2014 (approximately 9 months post-
intervention) to a different cohort of junior doctors at
the same point in their training year, and to all phar-
macists employed at each time point. Mean scores
were compared pre-intervention and post-intervention
using independent samples t-tests, with p<0.05 indi-
cating statistical significance for the overall feedback
effectiveness scales and p<0.01 for each of the indi-
vidual items (to account for multiple testing).
Two focus groups were conducted at site 1, one for
junior doctors and one for pharmacists, to explore
views on our interventions in more detail. Four main
topics were explored: prescriber identification and
name stamps, prescriber identification run charts,
individual feedback of prescribing errors and prescrib-
ing tip emails. Unintended consequences of the inter-
ventions were also explored. Discussions were
recorded and professionally transcribed. We used the-
matic analysis21 with a deductive approach using an a
priori framework of the perceived advantages, disad-
vantages, facilitators and barriers of each intervention.
Prescribing error prevalence
We studied the prevalence of erroneous medication
orders written by junior doctors at site 1 (interven-
tion) and site 2 (control) using identical methods on
each site. Following verbal and written briefings,
including our definition of a prescribing error,22 ward
pharmacists collected data once weekly from August
to December 2013 on any prescribing errors identi-
fied in the first 10 junior doctors’ medication orders
encountered, using the signature logs produced by the
project team. Errors were classified based on previous
work2; each medication order could have more than
one error. We used interrupted time series analysis to
test for an effect of our intervention on weekly pre-
scribing error rate at the intervention site, controlling
for baseline variation in error rates and longitudinal
variation in error rates at the control site.23 The time
series components of the model were fitted as
segmented regression with parameters representing
baseline trend, intervention onset and the post-
intervention change in trend. A significant reduction
in weekly error rate and/or trend in error rate, as indi-
cated by p<0.05 for the value of t associated with
each parameter coefficient, would indicate a positive
effect of the intervention.
Figure 2 presents the study timeline. An action–
effect diagram24 is presented in figure 3.
Ethical issues
The study was approved locally as a service evalu-
ation; NHS ethics approval was not required. Data
could not be attributed to individual patients or staff.
Focus group participants provided written informed
consent.
RESULTS
Course of the intervention
Following a series of four PDSA cycles, name stamps
and supporting information were distributed to all
junior doctors at site 1 during their induction in
August 2013, before they started patient care.
Pharmacists were briefed on providing feedback
during July and August 2013. We estimate that around
half of the department’s pharmacists attended a
face-to-face training session. Through regular publicity,
including presentations at pharmacy staff meetings,
posters and emails, we are confident that all pharma-
cists were aware of our aims. Following three PDSA
cycles, prescribing tip emails were produced every fort-
night starting August 2013. All interventions were sub-
sequently rolled out during January 2014 to also
include all junior doctors and pharmacists at site 2.
Process measures
Prescriber identification
At site 1, 11 374 medication orders were examined
over 29 weeks post-intervention (mean 392 per
week). The prescriber’s name was present for 5935
(52.2%), of which 3617 (60.9%) were stamped
names. No comparative baseline data were available
for site 1 as the interventions were introduced con-
temporaneously with the junior doctors starting
employment.
At site 2, where the interventions were introduced
later, 789 medication orders were examined at
Figure 2 Project timeline.
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baseline over 3 weeks (mean 263 per week) and 2332
during six post-intervention weeks (mean 389 per
week). Pre-intervention, the prescriber’s name was
specified on 48 of 789 (6.1%) medication orders; this
increased to 860 of 2332 (36.9%) post-intervention
(p<0.0001; χ2 test), of which 501 (58.3%) were
stamped.
Pharmacists’ provision of individual feedback
Senior clinical pharmacists recorded data for five peer-
reviewed ward visits that took place at site 1 between
August and December 2013. In three of the five visits,
pharmacists ‘always’ attempted to contact the original
prescriber and provided feedback in a professional
manner and in the remaining two visits this was done
‘mostly’ as assessed by the peer reviewer. Signposting
to suitable resources or solutions was done less
consistently.
Outcome measures
Junior doctors’ and pharmacists’ perceptions of feedback
At baseline (Spring 2013), we received questionnaire
responses from 25 of 37 (68%) site 1 pharmacists and
26 of 34 (76%) junior doctors. At the second time
point (Spring 2014), we received 18 of 32 (56%)
pharmacist responses and 21 of 30 (70%) from junior
doctors. For the overall feedback effectiveness scale
scores, the mean score for junior doctors increased
slightly post-intervention (mean at baseline=6.15,
SD=0.74; mean post-intervention=6.23; SD=0.86),
but was not statistically significant (p=0.74; unpaired
t-test). The mean score for pharmacists improved sig-
nificantly post-intervention (mean at baseline=5.26,
SD=0.88; mean post-intervention=5.84, SD=0.80;
p=0.03). For the junior doctors’ responses, improve-
ment was observed in the mean response for five indi-
vidual items, although none reached statistical
significance (see online supplementary appendix S4).
For pharmacists, there was improvement in 14 items.
Two reached statistical significance at p<0.01: percep-
tions of the accuracy of feedback delivered to junior
doctors (item 15; p=0.003) and perceptions of
whether junior doctors found the data to be trust-
worthy (item 16; p=0.007), with improvements in
mean scores of 1.4 and 0.87, respectively.
A total of 14 doctors (42% of 33 at site 1) attended
the junior doctors’ focus group in October 2013, all
of whom participated in the discussion. Participants
expressed positive views and experiences of receiving
feedback and reported increased understanding of the
Figure 3 Prescribing improvement action–effect diagram.
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importance of ensuring their identity is known when
prescribing. Prescriber identification run charts and
prescribing tips were well received and thought to be
useful, although some felt fortnightly run charts were
too frequent. Quotes are presented in table 1.
Four pharmacists attended the pharmacists’ focus
group in November 2013. Pharmacists felt that feed-
back was generally well received, although they felt
uncomfortable referring explicitly to ‘errors’ and
seemed protective of relationships with their junior
doctor colleagues. They preferred to use the terms
‘mistake’ or ‘incorrect’. They felt that pharmacists
were providing more individualised feedback due to
increased awareness of the benefits and had add-
itionally used the prescribing tips to facilitate discus-
sions. No unintended negative consequences were
identified by either group. An unintended positive
consequence was junior doctors using the name
stamps in the written health records as well as for
prescribing.
Prescribing error prevalence
We identified 390 errors in 367 (15.2%) of 2410
medication orders at site 1 and 391 errors in 368
(15.1%) of 2432 medication orders at site 2 (table 2).
Overall, the most common error types (see online
supplementary appendix S5) were ‘incorrect dose’
(175 of 781 errors; 22%) and ‘medication omitted
when clinically indicated’ (172; 22%), usually involv-
ing omission of patients’ usual medication following
hospital admission.
Over the course of the project, the mean weekly
prescribing error rate at both sites increased between
baseline and follow-up periods. When an interrupted
time series model was fitted to examine the change in
mean error rate, while controlling for baseline vari-
ation and compared with the control site, no signifi-
cant effect of the intervention at site 1 was observed.
The overall effect of intervention implementation (ie,
the unique effect associated with the intervention
while holding baseline trend and control constant)
was a non-significant reduction in the error rate of
4% (β=−4.045; t=−0.638; p=0.532). Similarly the
estimated trend in error rate was a non-significant
decrease of 4% post-intervention (β=−4.440;
t=−1.097; p=0.288).
DISCUSSION
A set of interventions were developed, refined and
implemented with the aim of reducing prescribing
errors made by junior doctors. Process measures and
qualitative findings indicate some benefits. Although
the net controlled effects of the interventions were
estimated decreases in both trend and level of weekly
prescribing error rates at the intervention site, these
did not reach statistical significance.
Relationship to other evidence
Our findings are in line with a Cochrane review and
more recent update,7 19 which suggest that providing
feedback results in small-to-moderate positive effects
on professional practice and that process measures
may be more sensitive to feedback initiatives than
outcome measures. However, these reviews focus on
studies of feedback on specific aspects of clinical
practice, such as prescribing for a particular clinical
condition; no studies of hospital prescribing errors
were included. Our prescribing error rate was com-
parable with UK studies employing similar
methodologies.2
Strengths and limitations
In designing an evaluation based on mixed methods
including a controlled interrupted time series analysis,
we have applied a robust quasi-experimental design to
a quality improvement initiative; such initiatives are
rarely subjected to this level of evaluation. We were
therefore able to examine any change in prescribing
error rates above and beyond those predicted by a
baseline trend which might, for example, describe
natural improvement in junior doctors’ prescribing as
they gain experience. Importantly, the survey and
qualitative components of this study allowed for gen-
eration of insights into the processes involved and
maximisation of the transferable value of the study.
The questionnaire had a good response rate and the
junior doctor focus group was well attended—we
believe the findings to be representative of the cohort.
Since only four pharmacists participated in their focus
Table 1 Quotes from junior doctors’ focus group
Intervention Quotes
Prescriber
identification
I think the fact that we’d been given the stamps
highlighted the fact more than anything that we
should be putting our names on the paperwork.
Now even when I don’t have my stamp I think, oh,
I’d better write my name because I don’t have
my stamp on me.
I find using the stamp makes me take a lot more
ownership of it, I think, do I really know what
I’m doing? I’m putting my name to that, like
George Foreman grill, it’d better work.
Individual feedback [The prescription] would need to be changed
[because of] patient safety, and that can be
done by anyone on the team, but I’d like to
know personally that I’d made a mistake.
…[I]t’s hard to say what it would be like without
[receiving feedback], it makes you feel safe
because it feels like every error you may be
making is being checked by somebody and that
they are then feeding back. So it feels like I’m
making less errors now because I’ve learnt from
the errors I’ve made.
Shared learning [The prescribing tips are] good because, there’s
often a picture of a drug chart so you can look
at it quite quickly and…You don’t have to read
a lot of text, you can just look and read, oh, I
can see just a gap, that … if you’re just quickly
checking it because you don’t have time.
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group, these results may represent a more specific set
of views.
The main limitation was that the new junior doctor
intake was contemporaneous with the initiation of our
interventions at site 1, potentially confounding detec-
tion of any effect of our intervention on error rates. A
longer pre-intervention baseline at both sites would
have been preferable. These issues were mainly due to
the dates for both project-funding and junior doctors’
inductions being fixed. Other limitations were that
senior pharmacists were only able to assess pharma-
cists’ feedback provision on five occasions, and we
recognise that pharmacists collecting prescribing error
data may vary in their adherence to data collection
procedures. Finally, we provided fortnightly run
charts to the junior doctors showing prescriber identi-
fication rates as we were collecting these data as part
of our evaluation. However this relied on manual data
collection and was quite time-consuming and so is
unlikely to be sustainable in routine practice.
Interpretation
We achieved our first objective of improving pre-
scriber identification, although it appears that the per-
centage of junior doctors’ medication orders for
which the prescriber could be identified hit a ceiling
of around 50%. Possible reasons for this are that
name stamps were lost or forgotten and for some sec-
tions of the medication chart the signature box is very
small. It is also difficult to depress the stamp onto the
chart without resting it on a firm surface (a particular
problem on ward rounds). Introducing a change
where junior staff may differ in practice to their
senior role models is also likely to be difficult. We
suspect that it will not be possible to achieve 100%
prescriber identification until inpatient electronic pre-
scribing is introduced. Routine use of signature logs
could form part of a solution in the meantime. We
also achieved our second objective of providing effect-
ive feedback to prescribers at both the individual level
and group level, with our interventions well received
by both pharmacists and junior doctors.
Critical analysis of our logic model (figure 1) sug-
gests why we may not have detected a significant
overall reduction in prescribing error rates. The
model is based on the assumption that increasing pre-
scriber identification would lead to increased feedback
by pharmacists, leading to changes in prescribing
behaviour and a reduction in prescribing error rates.
A feedback initiative of this type therefore relies on
reliable identification of potential ‘learners’, oppor-
tunities for the timely communication of relevant and
credible feedback, interaction with individual psych-
ology to produce ‘learning’ and an environment con-
ducive with implementing that learning in practice.
Our work highlights the need for a more comprehen-
sive theory of change in this area, underpinned by
broad synthesis of theory and experience across a
range of application contexts, to understand how con-
textual and intervention factors affect the success of
feedback initiatives. For example, we were only able
to increase the identification of junior doctor prescri-
bers to about 50%. Although a substantial increase
from baseline, this meant that the prescriber still
could not be identified for 50% of medication orders,
thus limiting opportunities for individual feedback.
We did not set out to assess the percentage of junior
doctors’ prescribing errors for which a pharmacist
gave individual feedback, but assume this would not
be 100% as time constraints, shift patterns and indi-
vidual motivation are likely to prevent some oppor-
tunities for feedback.
Prescribing errors are multifactorial2 4 5 25 26 and it
is likely that feedback would only prevent a subset,
especially if feedback relates to drugs that are rarely
prescribed. One of our most common error types
related to medication reconciliation on admission,
which may be largely a system problem and less ame-
liorable through individual feedback. Detection of
effects of feedback on error rates is likely to require
sustained monitoring over longer time periods, with
an adequate baseline, comprehensive monitoring of
compliance with the intervention and stable partici-
pant groups over baseline and intervention periods.
Based on our experience here, we would recommend
at least 3 months’ weekly error rate data be collected
both pre-intervention and post-intervention, with
quasi-experimental control over potential confoun-
ders (such as changes in junior doctor cohort)
through careful selection of a comparable control
site. These methodological requirements may repre-
sent a significant challenge, but our study suggests
that effective feedback on prescribing errors has the
potential to support beneficial learning. The impact
on prescribing errors, ideally in combination with
other interventions, therefore warrants further investi-
gation. Further work should also explore how infor-
mation technology could be used to deliver
individualised feedback around prescribing errors in
the hospital setting.
Table 2 Error rates for intervention and control sites
Site
Pre-intervention
erroneous medication orders
(% of all medication orders)
Post-intervention
erroneous medication orders
(% of all medication orders)
Overall
erroneous medication orders
(% of all medication orders)
1 (intervention) 92 of 620 (14.8) 275 of 1790 (15.4) 367 of 2410 (15.2)
2 (control) 35 of 276 (12.7) 333 of 2156 (15.5) 368 of 2432 (15.1)
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Lessons learnt from the project’s evolution
We identified a number of learning points from our
PDSA cycles. We found that the names some doctors
used in practice differed from their given names
(such as use of their middle name rather than their
first name) and we subsequently attempted to estab-
lish and use preferred names on the name stamps.
Some doctors initially believed that the stamp
replaced a prescribing signature; we clarified that a
signature was required alongside a stamp. The PDSA
approach allowed us to identify and address such
issues early on.
Locally, we now issue name stamps to all junior
doctors and non-medical prescribers. We audit pre-
scriber identification annually and continue to send
out fortnightly prescribing tips. The requirement of
providing feedback to the initial prescriber has been
incorporated into pharmacy standard operating proce-
dures. Our interventions were subsequently intro-
duced at two further large teaching hospitals within a
different organisation and are now being rolled out
across North West London.
CONCLUSION
Using a set of three linked interventions, we increased
the percentage of medication orders for which junior
doctor prescribers stated their name from about 10%
to 50%. Principles of effective feedback were devel-
oped in conjunction with junior doctors and both
quantitative and qualitative evaluation suggested an
improvement in experiences around feedback. No
change in prescribing error prevalence was detected.
Attempts to produce a measureable reduction in pre-
scribing errors are likely to need a multifaceted
approach of which feedback should form part.
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